Effect of health insurance coverage on outcome for heart failure in high-risk patients

Ishak A Mansi1, Runhua Shi, Ryan Altenburg

  • 1Brooke Army Medical Center, San Antonio, Texas, USA.

Insights

Health insurance status did not significantly impact clinical outcomes for heart failure patients. This study found no link between insurance type and in-hospital death or readmission rates.

Area of Science:

  • Cardiology
  • Health Services Research
  • Public Health

Background:

  • Lack of health insurance is associated with poorer patient health outcomes.
  • Understanding the impact of insurance on chronic conditions like heart failure is crucial.

Purpose of the Study:

  • To investigate the association between health insurance coverage and clinical outcomes in patients diagnosed with chronic heart failure.
  • To compare outcomes across different types of health insurance.

Main Methods:

  • A retrospective cohort study was conducted on 646 heart failure patients admitted to a Louisiana university hospital between 2003-2004.
  • Patients were categorized into four groups based on insurance status: uninsured, comprehensive government insurance, government insurance for services only, and commercial insurance.
  • Clinical outcomes, including in-hospital mortality, readmission rates, and heart failure serum markers, were analyzed.

Main Results:

  • Health insurance coverage was not found to be a significant predictor of in-hospital death, readmission rates, or serum markers for heart failure.
  • Significant demographic and clinical differences (age, ethnicity, comorbidities, substance use) were observed among the insurance groups.
  • The type of health insurance did not correlate with improved clinical outcomes in this patient population.

Conclusions:

  • Neither the presence nor the type of health insurance was associated with improved clinical outcomes for heart failure patients in this Louisiana hospital setting.
  • Social and demographic disparities exist among patients based on their insurance status.
  • Further research may be needed to explore other factors influencing outcomes in insured versus uninsured heart failure patients.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...